There are several companies and groups of researchers racing to bring an artificial pancreas to market, be it one that automates insulin delivery or one that does this and provides glucagon, as well. Bigfoot’s approach to automated insulin delivery is what we call “human-centered” automation.

General News Type 1 Diabetes Type 2 Diabetes Affordable Care Act (ACA) "Obamacare" Children's Health Insurance Program (CHIP) health insurance insulin medicaidBetween November 1, 2017 and December 15, 2017, uninsured people in the United States can purchase health insurance through the Health Care Marketplace. During open enrollment, as this period is called, everyone can purchase a health care plan even if they have a pre-existing condition.

The current prototype features a touchscreen interface, chambers for both insulin and glucagon, built-in Dexcom and control algorithm integration, and wireless CGM calibration via a paired blood glucose meter (so you cannot incorrectly enter the meter value). The hope is for a pivotal study to take place across the United States from early 2017 to early 2018, and an FDA review to overlap from late 2017 to late 2018. It's called the "iLet" (think pancreatic "islets").

The artificial pancreas-a device which monitors blood glucose in patients with type 1 diabetes and then automatically adjusts levels of insulin entering the body-is likely to be available by 2018, conclude authors of a paper in Diabetologia.

Existing insulin pumps could soon be a thing of the past, with research showing that automated, artificial pancreases may be available by 2018 Sufferers of type 1 diabetes are required to constantly monitor their blood glucose levels and administer insulin as needed. MORE >>

These trials will focus on fully automated insulin delivery systems, as well as an automated insulin and glucagon delivery system. They are slated for 2017 and 2018, and will take place in the U.S., The International Diabetes Closed-Loop Trial is a 6-month trial to test a smartphone-based automated insulin delivery system called inControl. Who They’re Recruiting: Up to 130 children with Type 1 (ages 6 – 19), who are already insulin pump users. MORE >>

1, 2018, and would cover most drugs for the province’s four million children and young adults. In 2016, a University of Toronto study found that children with Type 1 diabetes from lower-income families had worse health outcomes on insulin pumps than their peers; researchers suggested this health disparity might have resulted because of the costs of pump supplies. Thanks for reading this Insulin Nation article. As the U.S. MORE >>